PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+2.87%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.56B
AUM Growth
+$2.56B
(-11%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-11.68%
Top 10 Holdings %
Top 10 Hldgs %
59.29%
Holding
159
New
16
Increased
42
Reduced
54
Closed
15
Top Buys
| 1 |
Cameco
CCJ
|
$74.8M |
| 2 |
Pinduoduo
PDD
|
$38.6M |
| 3 |
Mobileye
MBLY
|
$28M |
| 4 |
Valaris
VAL
|
$15.7M |
| 5 |
Carlisle Companies
CSL
|
$10.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$63.9M |
| 2 |
Gilead Sciences
GILD
|
$53.6M |
| 3 |
Suncor Energy
SU
|
$46.6M |
| 4 |
Scorpio Tankers
STNG
|
$34.4M |
| 5 |
ZTO Express
ZTO
|
$32.9M |
Sector Composition
| 1 | Consumer Discretionary | 18.32% |
| 2 | Technology | 17.4% |
| 3 | Industrials | 16.93% |
| 4 | Energy | 15.13% |
| 5 | Financials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
26
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $18.1M | 0.71% |
2,335,992
+642
| +0% | +$4.98K |
|
27
Quanterix
QTRX
$202M
| $17.9M | 0.7% |
659,468
-56,533
| -8% | -$1.53M |
|
28
Recursion Pharmaceuticals
RXRX
$2.02B
| $17.9M | 0.7% |
2,335,132
-376,016
| -14% | -$2.88M |
|
|
DDL
29
Dingdong
DDL
$449M
| $17.8M | 0.7% |
9,142,209
-504,130
| -5% | -$983K |
|
30
JD.com
JD
$44.2B
| $15.9M | 0.62% |
547,343
+62,129
| +13% | +$1.81M |
|
31
DoorDash
DASH
$106B
| $15.6M | 0.61% |
196,850
-15,000
| -7% | -$1.19M |
|
32
Huazhu Hotels Group
HTHT
$11.2B
| $13.6M | 0.53% |
345,234
-19,918
| -5% | -$785K |
|
|
33
Alphabet (Google) Class A
GOOGL
$2.79T
| $12.9M | 0.5% |
98,827
-488,656
| -83% | -$63.9M |
|
34
Booking.com
BKNG
$181B
| $12.2M | 0.48% |
3,964
-5,564
| -58% | -$17.2M |
|
|
XYZ
35
Block, Inc.
XYZ
$46.2B
| $11.6M | 0.45% |
261,491
+3,289
| +1% | +$146K |
|
36
Iris Energy
IREN
$7.67B
| $9.67M | 0.38% |
2,607,072
-26,087
| -1% | -$96.8K |
|
37
Immunovant
IMVT
$2.91B
| $8.67M | 0.34% |
225,939
-102,903
| -31% | -$3.95M |
|
38
Moderna
MRNA
$9.36B
| $8.4M | 0.33% |
81,336
+43,210
| +113% | +$4.46M |
|
39
Planet Fitness
PLNT
$8.55B
| $8.25M | 0.32% |
167,685
-19,751
| -11% | -$971K |
|
40
Lam Research
LRCX
$124B
| $8.22M | 0.32% |
13,110
-38
| -0.3% | -$23.8K |
|
41
Adobe
ADBE
$148B
| $7.85M | 0.31% |
15,394
+15,127
| +5,666% | +$7.71M |
|
42
BioNTech
BNTX
$24.1B
| $7.42M | 0.29% |
68,338
+2,500
| +4% | +$272K |
|
43
Freeport-McMoran
FCX
$66.3B
| $7.4M | 0.29% |
198,478
| – | – |
|
44
Roivant Sciences
ROIV
$8.6B
| $6.99M | 0.27% |
598,732
-159,843
| -21% | -$1.87M |
|
45
Johnson & Johnson
JNJ
$429B
| $6.64M | 0.26% |
42,647
| – | – |
|
46
Microsoft
MSFT
$3.76T
| $6.55M | 0.26% |
20,736
+172
| +0.8% | +$54.3K |
|
47
Biogen
BIIB
$20.8B
| $6.18M | 0.24% |
24,044
| – | – |
|
48
Apogee Therapeutics
APGE
$2.27B
| $6.04M | 0.24% |
+283,683
| New | +$6.04M |
|
|
BCYC
49
Bicycle Therapeutics
BCYC
$492M
| $5.74M | 0.22% |
+285,479
| New | +$5.74M |
|
50
908 Devices
MASS
$199M
| $5.56M | 0.22% |
834,824
-40,623
| -5% | -$271K |
|